Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy

Circulation

Volumn 95, Issue 10, 1997, Pages 2434-2440

  Ortiz Lopez, Rocio ^a   Li, Hua ^a   Su, Jason ^a   Goytia, Veronica ^a   Towbin, Jeffrey A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cardiomyopathy; dystrophin; genetics; mutation

Indexed keywords

DYSTROPHIN;

ARTICLE; CHROMOSOME XP; DNA SEQUENCE; GENETIC LINKAGE; GENETIC POLYMORPHISM; HEART DILATATION; HUMAN; MISSENSE MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; X CHROMOSOME LINKAGE;

EID: 0030922569     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.10.2434     Document Type: Article

References (68)

1. Dec GW, Fuster V. Idiojpathic dilated cardiomyopathy. N Engl J Med. 1994;331:1564-1575.
2. Manolio TA, Baughman KL, Rodiheffer R, Perason TA, Bristow JD, Michels VV, Abelmann WH, Harlan WR. Prevalerce and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol. 1992;17: 1458-1466.
3. Evans RW. Measuring the costs of heart transplantation. Primary Cardiol. 1994;20:48-54.
4. Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Burnett JC, Rodeheffer RJ, Chesebro JH, Tazelaar HD. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992;326:77-82.
5. Keeling PJ, Gang Y, Smith G, Seo H, Bent SE, Murday V, Caforio AL, McKenna WJ. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J. 1995;73:417-421.
6. Towbin JA. Molecular genetic aspects of cardiomyopathy. Biochem Med Metab Biol. 1993;49:285-320.
7. Emanuel R, Withers R, O'Brien K. Dominant and recessive modes of inheritance in idiopathie cardiomyopathy. Lancet. 1971;2:1065-1067.
8. Berko BA, Swift M. X-linked dilated cardiomyopathy. N Engl J Med. 1987;316:1186-1191.
9. Towbin JA, Hejtmancik JF, Brink P, Belb B, Zhu XM, Chamberlain JS, McCabe ER, Swift M. X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 1993;87:1854-1865.
10. Towbin JA. Biochemical and molecular characterization of X-linked dilated cardiomyopathy (XLCM). In: Clark EB, Markwald RR, Takao A, eds. Developmental Mechanisms of Heart Disease. Armonck, NY: Futura Publishing Co Inc; 1995:121-132.
11. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987;50:509-517.
12. Hoffman EP, Brown RH, Kunkel LM. The protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919-928.
13. Boyce FM, Beggs AH, Feener C, Kunkel LM. Dystrophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci USA. 1991;88:1276-1280.
14. Feener CA, Koenig M, Kunkel LM. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature. 1989;338:509-511.
15. Nudel U, Zuk D, Einat P, Zeelon E, Levy Z, Neuman S, Yaffe D. Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature. 1989;337:76-78.
16. Klamut HJ, Gangopadhyay SB, Worton RG, Ray PN. Molecular and functional analysts of the muscle specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol. 1990;10:193-205.
17. Gorecki DC, Monaco AP, Derry JMJ, Walker AP, Barnard EA, Barnard PJ. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet. 1992;1:505-510.
18. Nishio H, Takeshima Y, Narita N, Yanagawa H, Suzuki Y, Ishikawa Y, Ishikawa Y, Minami R, Nakamura H, Matsuo M. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J Clin Invest. 1994;94:1037-1042.
19. Koenig M, Monaco AP, Kunkel LM. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988;53:219-228.
20. Klietsch R, Ervasti JM, Arnold W, Campbell KP, Jorgensen AO. Dystrophin-glycoprotein complex and lamina colocalize to the sarcolemma and transverse tubules of cardiac muscle. Circ Res. 1993;72:349-360.
21. Campbell KP, Kahl SD. Association of dystrophy and an integral membrane glycoprotein. Nature. 1989;338:259-262.
22. Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell. 1991;66:1121-1131.
23. Michalak M, Zubrzycka-Gaarn EE. Identification of dystrophin in cardiac sarcolemmal vesicles. Biochem Biophys Res commun. 1990;169:565-570.
24. Yoshida M, Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem. 1990;108:748-752.
25. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 1992;355:696-702.
26. Matsumura K, Nonaka I, Tome FM, Arahata K, Collin H, Leturcq F, Recan D, Kaplan JC, Fardeau M, Campbell KP. Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin. Am J Hum Genet. 1993;53:409-416.
27. Ohiendieck K, Matsumura K, Ionasescu VV, Towbin JA, Bosch EP, Weinstein SL, Sernett SW, Campbell KP. Duchenne muscular dystrophy: deficiency of the dystrophin-associated proteins in the sarcolemma. Neurology. 1993;43:795-800.
28. Tinsley JM, Blake DJ, Zuellig RA, Davies KE. Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci USA. 1994:91:8307-8313.
29. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu MG, Cianchetti C, Realdi G, Cao A, Melis MA, Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 1993; 329:921-925.
30. Muntoni F, Melis MA, Ganau A, Dubowitz V. Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy. Am J Hum Genet. 1995;56:151-157.
31. Muntoni F, Melis MA, Ganau A, Duhowitz V. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest. 1995;96:693-699.
32. Holder E. Maeda M, Bies RD. Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain. Hum Genet. 1996;97:232-239.
33. Vitiello L, Mostacciuolo ML, Oliviero S, Schiavon F, Nicoletti L, Angelini C, Danieli GA. Screening for mutations in the muscle promoter region and for exonic deletions in a series of 115 DMD and BMD patients. J Med Genet. 1992;29:127-130.
34. Beggs AH, Hoffman EP, Snyder JR, Arahata K, Specht L, Shapiro F, Angelini C, Sugita H, Kunkel LM. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet. 1991;49:54-67.
35. Yoshida K, Ikeda S, Nakamura A, Kagoshima M, Takeda S, Shoji S. Yanagisawa N. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscles Nerve. 1993;16:1161-1166.
36. Towbin JA, Ortiz-Lopez R. X-linked dilated cardiomyopathy is not due to a muscular promoter deletion in dystrophin in three families. N Engl J Med. 1994;330:369-370.
37. Milasin J, Muntoni F, Severini GM, Bartoloni L, Vatta M, Krajinovic M, Mateddu A, Angelini C, Camerini F. Falaschi A, Mestroni L, Giacca M, and HMD Study Group. A point mutation in the 5 splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet. 1996;5:73-79.
38. Miller G, Lisco H, Stitt D. Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody. Proc Soc Exp Biol Med. 1971;137:1459-1465.
39. Roberts RG, Darby TFM, Manners E, Bobrow M, Bentley DR. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet. 1991;49:298-310.
40. Beggs AH, Koenig M, Boyce FM, Kunkel LM. Deletion of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990;86:45-48.
41. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988;23:11141-11156.
42. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989;5:874-879.
43. Wang Q, Keating MT. Isolation of P1 inserts ends by direct sequencing. Biotechniques. 1994;17:282-284.
44. Marchuk D, Drumm M, Saulino A, Collins FS. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res. 1990;19:1154.
45. Solovyev VV, Salamov AA. Secondary structure prediction based on discriminant analysis. In: Kolchanov NA, Lim HA, eds. Computer Analysis of Genetic Macromolecules. World Scientific; 1994:352-364.
46. Solovyev VV, Salamov AA. Predicting α-helix and β-strand segments of globular proteins. Comput Appl Biosci. 1994;10:661-669.
47. Garnier J, Osguthorpe DJ, Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978;120:97-120.
48. Roberts RG, Coffey A, Bobrow M, Bentley DR. Exon structure of the human dystrophin gene. Genomics. 1993;16:536-538.
49. Koenig M, Kunkel LM. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem. 1990;265:4560-4566.
50. Lemaire C, Helig R, Mandel JL. Nucleotide sequence of chicken dystrophin cDNA. Nucleic Acids Res. 1988;16:11815-11816.
51. Chang HW, Bock E, Bonilla E. Dystrophin in electric organ of Torpedo californica homologous to that in human muscle. J Biol Chem. 1989;263:20831-20834.
52. Byers TJ, Husain-Chishti A, Dubreuil RR, Branton D, Goldstein LSB. Sequence similarity of the amino-terminal domain of Drosophila beta spectrin to alpha actinin and dystrophin. J Cell Biol. 1989;109:1633-1641.
53. Bartlett RJ, Sharp NJH, Secure SL, Hung WY, Kornegay JN, Roses AD. The canine and human DYS genes are highly conserved. J Neurol Sci. 1990;98(suppl):165. Abstract.
54. Ryder-Cook AS, Sicinski P, Thomas K, Davies KE, Worton RG, Barnard EA, Darlison MG, Barnard PJ. Localisation of the mdx mutation within the mouse dystrophin gene. EMBO J. 1988;7:3017-3021.
55. Kahana E, Marsh PJ, Henry AJ, Way M, Gratzer WB. Conformation and phasing of dystrophin structural repeats. J Mol Biol. 1994;235:1271-1277.
56. Ahn AH, Kunkel LM. The structural and functional diversity of dystrophin. Nat Genet. 1993;3:283-291.
57. Hammonds RG Jr. Protein sequence of DMD gene is related to actinbinding domain of alpha-actinin. Cell. 1987;51:1. Letter.
58. Davidson MD, Baron MD, Critchley DR, Wootton JC. Structural analysis of homologous repeated domains in alpha-actinin and spectrin. Int J Biol Macromol. 1989;11:81-90.
59. Speicher DW, Marchesi VT. Erythrocyte spectrin is comprised of many homologous triple helical segments. Nature. 1984;311: 177-180.
60. Sherratt TG, Vulliamy T, Strong PN. Evolutionary conservation of the dystrophin central rod domain. Biochem J. 1992; 287:755-759.
61. Gurusinghe AD, Wilce MCJ, Austin L, Hearn MTW. Duchenne muscular dystrophy and dystrophin: sequence homology observations. Neurochem Res. 1991;16:681-686.
62. Malhotra SB, Hart KA, Klamut HJ, Thomas NS, Bodrug SE, Burghes AH, Bobrow M, Harper PS, Thompson MW, Ray PN, Worton RG. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science. 1988;242:755-759.
63. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Muller CR, Lindlof M, Kaariainen H, de la Chapelle A, Kiuru A, Savontaus ML, Gilgenkrants H, Recan D, Chelly J, Kaplan JC, Covone AE, Archidiacono N, Romeo G, Liechti-Gallati S, Schneider V, Braga S, Moser H, Darras BT, Murphy P, Francke U, Chen JD, Morgan G, Denton M, Greenberg CR, Van Ommen GJB, Kunkel LM. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989;45:498-506.
64. Reiss J, Rininsland F. An explanation for the constitutive exon 9 cassette splicing of the DMD gene. Hum Mol Genet. 1994;3: 295-298.
65. Roberts RG, Gardner RJ, Bobrow M. Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Hum Mutat. 1994;4:1-11.
66. Prior TW, Bartolo C, Pearl DK, Papp AC, Snyder PJ, Sedra MS, Burghes AHM, Mendell JR. Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet. 1995;57:22-33.
67. Grimm T, Meng G, Liechti-Gallati S, Bettecken T, Muller CR, Muller B. On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis. J Med Genet. 1994;31:183-186.
68. Kilimann MW, Pizzuti A, Grompe M, Caskey CT. Point mutations and polymorphisms in the human dystrophin gene identified in genomic DNA sequences amplified by multiplex PCR. Hum Genet. 1992;89:253-258.